<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31344216</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>05</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">0717-6163</ISSN><JournalIssue CitedMedium="Internet"><Volume>147</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Revista medica de Chile</Title><ISOAbbreviation>Rev Med Chil</ISOAbbreviation></Journal><ArticleTitle>[Thymoma in a patient with klinefelter syndrome. Case report].</ArticleTitle><Pagination><StartPage>518</StartPage><EndPage>521</EndPage><MedlinePgn>518-521</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4067/S0034-98872019000400518</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0034-98872019000400518</ELocationID><Abstract><AbstractText>Klinefelter syndrome (47, XXY in most cases) is a frequently underdiagnosed chromosomal anomaly associated with multiple comorbidities in adult life. Patients with Klinefelter syndrome have a higher risk of cancer. Specifically, these patients have a higher risk for mediastinal germ cell tumors. It is estimated that 8% of male patients with mediastinal tumors have Klinefelter. We report a 42-years-old male who suffered recurrent respiratory infections. During the study, a mediastinal mass was found, whose pathological study disclosed a type B thymoma. The patient had a history of infertility, high stature, gynecomastia, obesity with gynecoid distribution of body fat and testicular atrophy. A karyotype was requested (47, XXY), confirming the diagnosis of Klinefelter syndrome.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Carriel-Mancilla</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Hospital Universitario Cl&#xed;nico San Carlos, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leone</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Farmacolog&#xed;a cl&#xed;nica, Hospital Universitario Cl&#xed;nico San Carlos, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borreguero-Mart&#xed;nez</LastName><ForeName>Encarnaci&#xf3;n</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Hospital Universitario Cl&#xed;nico San Carlos, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz-Artacho</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Universitario Cl&#xed;nico San Carlos, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tornero-Romero</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Hospital Universitario Cl&#xed;nico San Carlos, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvo-Manuel</LastName><ForeName>Elpidio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Hospital Universitario Cl&#xed;nico San Carlos, Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>S&#xed;ndrome de Klinefelter diagnosticado en un adulto a ra&#xed;z del estudio de infecci&#xf3;n respiratoria recurrente y masa mediast&#xed;nica. Caso cl&#xed;nico.</VernacularTitle></Article><MedlineJournalInfo><Country>Chile</Country><MedlineTA>Rev Med Chil</MedlineTA><NlmUniqueID>0404312</NlmUniqueID><ISSNLinking>0034-9887</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007713" MajorTopicYN="N">Klinefelter Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008479" MajorTopicYN="N">Mediastinal Neoplasms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013902" MajorTopicYN="N">Radiography, Thoracic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013945" MajorTopicYN="N">Thymoma</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013953" MajorTopicYN="N">Thymus Neoplasms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31344216</ArticleId><ArticleId IdType="doi">10.4067/S0034-98872019000400518</ArticleId><ArticleId IdType="pii">S0034-98872019000400518</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27821895</PMID><DateCompleted><Year>2017</Year><Month>02</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1657-9534</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>3</Issue><PubDate><Year>2016</Year><Month>Sep</Month><Day>30</Day></PubDate></JournalIssue><Title>Colombia medica (Cali, Colombia)</Title><ISOAbbreviation>Colomb Med (Cali)</ISOAbbreviation></Journal><ArticleTitle>Health care utilization of mexican patients with medically unexplained physical symptoms.</ArticleTitle><Pagination><StartPage>155</StartPage><EndPage>159</EndPage><MedlinePgn>155-159</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine the prevalence of medically unexplained physical symptoms and the characteristics and use of health services in a group of patients with medically unexplained physical symptoms and a group of patients with other illnesses.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a cross-sectional, retrospective and multicenter study. We included 1,043 patients over 18 years of age from 30 primary care units of a government health institution, in 11 states of Mexico, attended by 39 family physicians. The prevalence of medically unexplained physical symptoms was determined and both groups with or without symptoms were compared with regard to drug use, laboratory and other studies, leaves of absence, and referrals in the last six months. The group with medically unexplained physical symptoms was diagnosed using the Patient Health Questionnaire and the diagnostic criteria of Reid <i>et al</i>. Emergency or terminal illnesses were excluded. The chi square test was used with a statistical significance of p &lt; 0.05.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Medically unexplained physical symptoms was diagnosed in 73 patients (7.0%). The majority were women (91.8%); their predominant symptom was from the gastrointestinal system in 56 (76.7%). This group had a greater use of clinical studies and referrals to other services (mean 1.1 vs. 0.5; <i>p</i> &lt;0.0001 and 0.6 vs. 0.8; <i>p</i> &lt; 0.01, respectively).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The prevalence of medically unexplained physical symptoms was low, but with a greater impact on some health services. This could represent an overload in medical costs.</AbstractText><AbstractText Label="OBJETIVO" NlmCategory="OBJECTIVE">Determinar la prevalencia de S&#xed;ntomas F&#xed;sicos Medicamente No Explicables y las caracter&#xed;sticas y uso de los servicios de salud entre el grupo de pacientes con S&#xed;ntomas F&#xed;sicos Medicamente No Explicables, y el grupo con otras enfermedades.</AbstractText><AbstractText Label="M&#xc9;TODOS" NlmCategory="UNASSIGNED">Estudio transversal, retroprospectivo y multic&#xe9;ntrico. Se incluyeron a 1,043 pacientes mayores de 18 a&#xf1;os, en 30 unidades de atenci&#xf3;n primaria de una instituci&#xf3;n gubernamental en salud, en 11 estados de la Rep&#xfa;blica Mexicana, atendidos por 39 m&#xe9;dicos familiares. Se estim&#xf3; la prevalencia de S&#xed;ntomas F&#xed;sicos Medicamente No Explicables y se compararon los dos grupos con y sin estos s&#xed;ntomas, en cuanto al uso de medicamentos, estudios de laboratorio, de gabinete, incapacidades y referencias en los &#xfa;ltimos seis meses. El grupo de S&#xed;ntomas F&#xed;sicos Medicamente No Explicables fue diagnosticado por el Patient Health Questionnaire (son los s&#xed;ntomas f&#xed;sicos m&#xe1;s com&#xfa;nmente referidos por estos pacientes en el primer nivel de atenci&#xf3;n), adem&#xe1;s de criterios diagn&#xf3;sticos de Reid <i>et al</i>. Se excluyeron urgencias o con enfermedad terminal. Se utiliz&#xf3; prueba Chi cuadrada con <i>p</i> &lt;0.05 para significancia estad&#xed;stica.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="RESULTS">El 7.0% (73) se diagnostic&#xf3; como S&#xed;ntomas F&#xed;sicos Medicamente No Explicables, la mayor&#xed;a mujeres (91.8%); el s&#xed;ntoma predominante pertenece al sistema gastrointestinal con 76.7% (56). Este grupo demand&#xf3; mayor uso de estudios de gabinete y referencias a otros servicios (media 1.1 vs. 0.5; <i>p</i> &lt;0.0001 y 0.8 vs 0.6; <i>p</i> &lt;0.01, respectivamente).</AbstractText><AbstractText Label="CONCLUSIONES" NlmCategory="CONCLUSIONS">La prevalencia de S&#xed;ntomas F&#xed;sicos Medicamente No Explicables fue baja, pero con impacto significativo en el uso de algunos servicios de salud. Esto pudiera representar un mayor costo comparado con otro grupo de pacientes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rodriguez Gonz&#xe1;lez</LastName><ForeName>Azucena Maribel</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Red Mexicana de Investigadores en Medicina Familiar A. C. Monterrey, Nuevo Leon Mexico, ; Secretaria de Salud de Nuevo Le&#xf3;n Monterrey, Nuevo Leon, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ram&#xed;rez Aranda</LastName><ForeName>Jos&#xe9; Manuel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Red Mexicana de Investigadores en Medicina Familiar A. C. Monterrey, Nuevo Leon Mexico, ; Hospital Universitario "Dr. Jos&#xe9; Eleuterio Gonz&#xe1;lez", Departamento de Medicina Familiar, Universidad Autonoma de Nuevo Leon, Facultad de Medicina, Monterrey, Nuevo Leon, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Los Santos Res&#xe9;ndiz</LastName><ForeName>Homero</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Colegio Mexicano de Medicina Familiar, Ciudad de Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lara Duarte</LastName><ForeName>Mar&#xed;a Yolanda</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Red Mexicana de Investigadores en Medicina Familiar A. C. Monterrey, Nuevo Leon Mexico, ; Facultad de Medicina de Tampico, Universidad Aut&#xf3;noma de Tamaulipas, Tamaulipas, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pazaran Zanella</LastName><ForeName>Santiago Oscar</ForeName><Initials>SO</Initials><AffiliationInfo><Affiliation>Red Mexicana de Investigadores en Medicina Familiar A. C. Monterrey, Nuevo Leon Mexico, ; Instituto Mexicano del Seguro Social, Ciudad de Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xe9;ndez L&#xf3;pez</LastName><ForeName>Jafet Felipe</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social, Ciudad de Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gil Alfaro</LastName><ForeName>Issa</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Red Mexicana de Investigadores en Medicina Familiar A. C. Monterrey, Nuevo Leon Mexico, ; Instituto Mexicano del Seguro Social, Ciudad de Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Islas Ruz</LastName><ForeName>F&#xe9;lix Gilberto</ForeName><Initials>FG</Initials><AffiliationInfo><Affiliation>Red Mexicana de Investigadores en Medicina Familiar A. C. Monterrey, Nuevo Leon Mexico, ; Instituto Mexicano del Seguro Social, Ciudad de Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navarrete Floriano</LastName><ForeName>Gloria</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Red Mexicana de Investigadores en Medicina Familiar A. C. Monterrey, Nuevo Leon Mexico, ; Instituto Mexicano del Seguro Social, Ciudad de Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guillen Salom&#xf3;n</LastName><ForeName>Edith</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Red Mexicana de Investigadores en Medicina Familiar A. C. Monterrey, Nuevo Leon Mexico, ; Instituto Mexicano del Seguro Social, Ciudad de Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Texon Fern&#xe1;ndez</LastName><ForeName>Obdulia</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Red Mexicana de Investigadores en Medicina Familiar A. C. Monterrey, Nuevo Leon Mexico, ; Instituto Mexicano del Seguro Social, Ciudad de Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cruz Duarte</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Red Mexicana de Investigadores en Medicina Familiar A. C. Monterrey, Nuevo Leon Mexico, ; Instituto Mexicano del Seguro Social, Ciudad de Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romo Salazar</LastName><ForeName>Juan Carlos</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Red Mexicana de Investigadores en Medicina Familiar A. C. Monterrey, Nuevo Leon Mexico, ; Instituto Mexicano del Seguro Social, Ciudad de Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rez Ruiz</LastName><ForeName>Claudia Elsa</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Red Mexicana de Investigadores en Medicina Familiar A. C. Monterrey, Nuevo Leon Mexico, ; Instituto Mexicano del Seguro Social, Ciudad de Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez Salas</LastName><ForeName>Sara de Jes&#xfa;s</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Red Mexicana de Investigadores en Medicina Familiar A. C. Monterrey, Nuevo Leon Mexico, ; Instituto Mexicano del Seguro Social, Ciudad de Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben&#xed;tez Amaya</LastName><ForeName>Lizbeth</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Red Mexicana de Investigadores en Medicina Familiar A. C. Monterrey, Nuevo Leon Mexico, ; Instituto Mexicano del Seguro Social, Ciudad de Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zapata Gallardo</LastName><ForeName>Javier Nahum</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social, Ciudad de Mexico, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Colombia</Country><MedlineTA>Colomb Med (Cali)</MedlineTA><NlmUniqueID>9212578</NlmUniqueID><ISSNLinking>0120-8322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071896" MajorTopicYN="Y">Medically Unexplained Symptoms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008800" MajorTopicYN="N">Mexico</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010342" MajorTopicYN="N">Patient Acceptance of Health Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="OBJETIVO:">Determinar la prevalencia de S&#xed;ntomas F&#xed;sicos Medicamente No Explicables y las caracter&#xed;sticas y uso de los servicios de salud entre el grupo de pacientes con S&#xed;ntomas F&#xed;sicos Medicamente No Explicables, y el grupo con otras enfermedades.</AbstractText><AbstractText Label="M&#xc9;TODOS:">Estudio transversal, retroprospectivo y multic&#xe9;ntrico. Se incluyeron a 1,043 pacientes mayores de 18 a&#xf1;os, en 30 unidades de atenci&#xf3;n primaria de una instituci&#xf3;n gubernamental en salud, en 11 estados de la Rep&#xfa;blica Mexicana, atendidos por 39 m&#xe9;dicos familiares. Se estim&#xf3; la prevalencia de S&#xed;ntomas F&#xed;sicos Medicamente No Explicables y se compararon los dos grupos con y sin estos s&#xed;ntomas, en cuanto al uso de medicamentos, estudios de laboratorio, de gabinete, incapacidades y referencias en los &#xfa;ltimos seis meses. El grupo de S&#xed;ntomas F&#xed;sicos Medicamente No Explicables fue diagnosticado por el Patient Health Questionnaire (son los s&#xed;ntomas f&#xed;sicos m&#xe1;s com&#xfa;nmente referidos por estos pacientes en el primer nivel de atenci&#xf3;n), adem&#xe1;s de criterios diagn&#xf3;sticos de Reid <i>et al</i>. Se excluyeron urgencias o con enfermedad terminal. Se utiliz&#xf3; prueba Chi cuadrada con <i>p</i> &lt;0.05 para significancia estad&#xed;stica.</AbstractText><AbstractText Label="RESULTADOS:">El 7.0% (73) se diagnostic&#xf3; como S&#xed;ntomas F&#xed;sicos Medicamente No Explicables, la mayor&#xed;a mujeres (91.8%); el s&#xed;ntoma predominante pertenece al sistema gastrointestinal con 76.7% (56). Este grupo demand&#xf3; mayor uso de estudios de gabinete y referencias a otros servicios (media 1.1 vs. 0.5; <i>p</i> &lt;0.0001 y 0.8 vs 0.6; <i>p</i> &lt;0.01, respectivamente).</AbstractText><AbstractText Label="CONCLUSIONES:">La prevalencia de S&#xed;ntomas F&#xed;sicos Medicamente No Explicables fue baja, pero con impacto significativo en el uso de algunos servicios de salud. Esto pudiera representar un mayor costo comparado con otro grupo de pacientes.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Somatization disorder</Keyword><Keyword MajorTopicYN="Y">ambulatory care</Keyword><Keyword MajorTopicYN="Y">family medicine</Keyword><Keyword MajorTopicYN="Y">healthcare institutions</Keyword><Keyword MajorTopicYN="Y">healthcare services</Keyword><Keyword MajorTopicYN="Y">physician-patient relations</Keyword><Keyword MajorTopicYN="Y">primary health care</Keyword><Keyword MajorTopicYN="Y">somatization</Keyword></KeywordList><CoiStatement>the authors declare no conflict of interest</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27821895</ArticleId><ArticleId IdType="pmc">PMC5091274</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pincus HA, Wise T, Michel BF. Manual diagn&#xf3;stico y estad&#xed;stico de los trastornos mentales. Barcelona: Masson; 2004.</Citation></Reference><Reference><Citation>McGorm K, Burton C, Weller D, Murray G, Sharpe M. Patients repeatedly referred to secondary care with symptoms unexplained by organic disease: prevalence, characteristics and referral pattern. Fam Pract. 2010;27:479&#x2013;486.</Citation><ArticleIdList><ArticleId IdType="pubmed">20679139</ArticleId></ArticleIdList></Reference><Reference><Citation>Aamland A, Malterud K, Werner EL. Patients with persistent medically unexplained physical symptoms: a descriptive study from Norwegian general practice. BMC Fam Pract. 2014;15:107&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4041895</ArticleId><ArticleId IdType="pubmed">24885524</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris R, Lindson N, Coupland C, Dex G, Avery A. Estimating the prevalence of medically unexplained symptoms from primary care records. Public Health. 2012;126:846&#x2013;854.</Citation><ArticleIdList><ArticleId IdType="pubmed">22922044</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimnuan C, Hotopf M, Wessely S. Medically unexplained symptoms: an epidemiological study in seven specialties. J Psychosom Res. 2001;51:361&#x2013;367.</Citation><ArticleIdList><ArticleId IdType="pubmed">11448704</ArticleId></ArticleIdList></Reference><Reference><Citation>Granel A. Pacientes con s&#xed;ntomas som&#xe1;ticos no explicables. Evid Actual Pract Ambul. 2006;9:176&#x2013;180.</Citation></Reference><Reference><Citation>Smith RC, Dwamena FC. Classification and diagnosis of patients with medically unexplained symptoms. J Gen Intern Med. 2007;22:685&#x2013;691.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1852906</ArticleId><ArticleId IdType="pubmed">17443380</ArticleId></ArticleIdList></Reference><Reference><Citation>American Psychiatric Association . Manual Diagn&#xf3;stico y Estad&#xed;stico de los Trastornos mentales DSM-5. 5ta Ed. Arligton VA: Editorial M&#xe9;dica Panamericana; 2014.</Citation></Reference><Reference><Citation>Reid S, Crayford T, Richards S, Nimnuan C, Hotopf M. Recognition of medically unexplained symptoms-do doctors agree. J Psychosom Res. 1999;47:483&#x2013;485.</Citation><ArticleIdList><ArticleId IdType="pubmed">10624846</ArticleId></ArticleIdList></Reference><Reference><Citation>van Ravesteijn H, Wittkampf K, Lucassen P. Detecting somatoform disorders in primary care with the PHQ-15. Ann Fam Med. 2009;7:232&#x2013;238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2682971</ArticleId><ArticleId IdType="pubmed">19433840</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid S, Wessely S, Crayford T, Hotopf M. Frequent attenders with medically unexplained symptoms: service use and costs in secondary care. Br J Psychiatry. 2002;180:248&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pubmed">11872517</ArticleId></ArticleIdList></Reference><Reference><Citation>Zonneveld LN, Sprangers MA, Kooiman CG, van't Spijker A, Busschbach JJ. Patients with unexplained physical symptoms have poorer quality of life and higher costs than other patient groups: a cross-sectional study on burden. BMC Health Serv Res. 2013;13:520&#x2013;520.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3878564</ArticleId><ArticleId IdType="pubmed">24344899</ArticleId></ArticleIdList></Reference><Reference><Citation>Bermingham SL, Cohen A, Hague J, Parsonage M. The cost of somatisation among the working-age population in England for the year 2008-2009. Ment Health Fam Med. 2010;7:71&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2939455</ArticleId><ArticleId IdType="pubmed">22477925</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating somatic symptom severity. Psychosom Med. 2002;64:258&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pubmed">11914441</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Feltz-Cornelis CM, Hoedeman R, Keuter EJ, Swinkels JA. Presentation of the Multidisciplinary Guideline Medically Unexplained Physical Symptoms (MUS) and Somatoform Disorder in the Netherlands: disease management according to risk profiles. J Psychosom Res. 2012;72:168&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pubmed">22281461</ArticleId></ArticleIdList></Reference><Reference><Citation>Barsky AJ, Orav EJ, Bates DW. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry. 2005;62:903&#x2013;910.</Citation><ArticleIdList><ArticleId IdType="pubmed">16061768</ArticleId></ArticleIdList></Reference><Reference><Citation>Escobar JI, Cook B, Chen CN, Gara MA, Alegr&#xed;a M, Interian A, et al. Whether medically unexplained or not, three or more concurrent somatic symptoms predict psychopathology and services use in community populations. J Psychosom Res. 2010;69:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2905311</ArticleId><ArticleId IdType="pubmed">20630257</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiderman A, Ilan U, Gur I, Bdolah-Abram T, Brezis M. Unexplained complaints in primary care: evidence of action bias. J Fam Pract. 2013;62:408&#x2013;413.</Citation><ArticleIdList><ArticleId IdType="pubmed">24143333</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmon P, Ring A, Dowrick CF, Humphris GM. What do general practice patients want when they present medically unexplained symptoms, and why do their doctors feel pressurized. J Psychosom Res. 2005;59(4):255&#x2013;260.</Citation><ArticleIdList><ArticleId IdType="pubmed">16223629</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosomatic Medicine. 2007;69:881&#x2013;888.</Citation><ArticleIdList><ArticleId IdType="pubmed">18040099</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith RC, Gardiner JC, Lyles JS, Johnson M, Rost KM, Luo Z, et al. Minor acute illness: a preliminary research report on the "worried well". J Fam Pract. 2002;51(1):24&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">11927058</ArticleId></ArticleIdList></Reference><Reference><Citation>Konnopka A, Kaufmann C, K&#xf6;nig HH. Association of costs with somatic symptom severity in patients with medically unexplained symptoms. J Psychosom Res. 2013;75:370&#x2013;375.</Citation><ArticleIdList><ArticleId IdType="pubmed">24119945</ArticleId></ArticleIdList></Reference><Reference><Citation>Olde Hartman T, Hassink-Franke L, Dowrick C. Medically unexplained symptoms in family medicine: defining a research agenda. Proceedings from WONCA 2007. Fam Pract. 2008;25:266&#x2013;271.</Citation><ArticleIdList><ArticleId IdType="pubmed">18596048</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawas-Valle O. Trastornos de somatizaci&#xf3;n en atenci&#xf3;n primaria. Medicina Universitaria. 2011;13:171&#x2013;172.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">8025189</PMID><DateCompleted><Year>1994</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0212-7199</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>1994</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Anales de medicina interna (Madrid, Spain : 1984)</Title><ISOAbbreviation>An Med Interna</ISOAbbreviation></Journal><ArticleTitle>[Spontaneous perforation of the esophagus: Boerhaave's syndrome. Apropos a case diagnosed by CT].</ArticleTitle><Pagination><StartPage>32</StartPage><EndPage>34</EndPage><MedlinePgn>32-4</MedlinePgn></Pagination><Abstract><AbstractText>The spontaneous perforation of the esophagus is an entity with a difficult diagnosis due to the absence of predisposing pathological antecedents and the variability of symptoms. Although the diagnosis may be clinically suspected, only the imaging techniques, mainly thoracic radiography, esophagogram and, most recently, axial computerized tomography and nuclear magnetic resonance, allow a reliable diagnosis. We present the case of a spontaneous perforation of the esophagus in which the image obtained with computerized tomography allowed its diagnosis and surgical treatment within a short period of time.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bascu&#xf1;ana Morej&#xf3;n</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Universitario San Carlos, Madrid.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Algarra Paredes</LastName><ForeName>J M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>V&#xe9;lez P&#xe9;rez</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Hermo Mosqueira</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Tarquis Alfonso</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Jim&#xe9;nez de Diego</LastName><ForeName>L</ForeName><Initials>L</Initials></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Perforaci&#xf3;n espont&#xe1;nea del es&#xf3;fago: s&#xed;ndrome de Boerhaave. A prop&#xf3;sito de un caso diagnosticado por TAC.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>An Med Interna</MedlineTA><NlmUniqueID>9112183</NlmUniqueID><ISSNLinking>0212-7199</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D004939" MajorTopicYN="N">Esophageal Perforation</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004947" MajorTopicYN="N">Esophagus</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="Y">Tomography, X-Ray Computed</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>15</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1994</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1994</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1994</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">8025189</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>